Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis. (Q48286199)
Jump to navigation
Jump to search
scientific article published in February 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis. |
scientific article published in February 1999 |
Statements
Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis (English)
Weinberg AD
Wegmann KW
Funatake C
1 February 1999